Amy N Courtney

11PUBLICATIONS
41CO-AUTHORS
Molecular targetsNanomaterialsInnate immunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 20, 2026
Coexpression of IL15 Promotes Effector Differentiation and Sustained Proliferative Capacity in ALPPL2-Specific Human CAR T Cells.

David Cunningham, Junquan Liu, Inci Cevher Zeytin

|Oct 21, 2025
Facts and Hopes of Chimeric Antigen Receptor-Redirected NK T Cells.

Amy N Courtney, Xin Zhou, Gengwen Tian

|Jan 17, 2025
PRDM1 Is a Key Regulator of the NKT-cell Central Memory Program and Effector Function.

Gengwen Tian, Gabriel A Barragan, Hangjin Yu

|May 15, 2023
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results.

Andras Heczey, Xin Xu, Amy N Courtney

|Dec 09, 2022
LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells.

Ho Ngai, Gabriel A Barragan, Gengwen Tian

|Nov 08, 2022
Natural killer T cells and other innate-like T lymphocytes as emerging platforms for allogeneic cancer cell therapy.

Amy N Courtney, Gengwen Tian, Leonid S Metelitsa

Pageof 2

Frequent Collaborators

8 joint publications

Leonid S Metelitsa

6 joint publications

Andras Heczey

5 joint publications

Xin Xu

3 joint publications

Claudia Martinez-Amador